Resources from the same session
LBA17 - Adjuvant abemaciclib plus endocrine therapy for HR+, HER2-, high-risk early breast cancer: Results from a preplanned monarchE overall survival interim analysis, including 5-year efficacy outcomes
Presenter: Nadia Harbeck
Session: Proffered Paper session - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
LBA18 - Pembrolizumab or placebo plus chemotherapy followed by pembrolizumab or placebo for early-stage TNBC: Updated EFS results from the phase III KEYNOTE-522 study
Presenter: Peter Schmid
Session: Proffered Paper session - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
LBA19 - Event-free survival (EFS) analysis of neoadjuvant taxane/carboplatin with or without atezolizumab followed by an adjuvant anthracycline regimen in high-risk triple negative breast cancer (TNBC): NeoTRIP Michelangelo randomized study
Presenter: Luca Gianni
Session: Proffered Paper session - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
Q&A
Presenter: All Speakers
Session: Proffered Paper session - Breast cancer, early stage
Resources:
Slides
Webcast
LBA20 - A randomized, double-blind trial of nivolumab (NIVO) vs placebo (PBO) with neoadjuvant chemotherapy (NACT) followed by adjuvant endocrine therapy (ET) ± NIVO in patients (pts) with high-risk, ER+ HER2− primary breast cancer (BC)
Presenter: Sherene Loi
Session: Proffered Paper session - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
LBA21 - KEYNOTE-756: Phase III study of neoadjuvant pembrolizumab (pembro) or placebo (pbo) + chemotherapy (chemo), followed by adjuvant pembro or pbo + endocrine therapy (ET) for early-stage high-risk ER+/HER2– breast cancer
Presenter: Fatima Cardoso
Session: Proffered Paper session - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
Invited Discussant LBA20 and LBA21
Presenter: Stephen Johnston
Session: Proffered Paper session - Breast cancer, early stage
Resources:
Slides
Webcast
Q&A
Presenter: All Speakers
Session: Proffered Paper session - Breast cancer, early stage
Resources:
Webcast